To disrupt the vicious cycle between tau protein and ROS, we developed an ultrasound‐assisted hydrogen emitter to enable hydrogen‐based gene therapy for the prevention of anesthesia/surgery‐induced cognitive impairment. The gene discussed is MAPT; the disease is Cognitive impairment.